UNDERWRITING AGREEMENT ROYALTY PHARMA PLC Underwriting AgreementUnderwriting Agreement • July 16th, 2021 • Royalty Pharma PLC • Pharmaceutical preparations • New York
Royalty Pharma plc, an English public limited company incorporated under the laws of England and Wales (the “Company”), Royalty Pharma Holdings Limited, a limited company incorporated under the laws of England and Wales and United Kingdom tax resident (the “Guarantor”) and RP Management, LLC, a Delaware limited liability company (the “Manager”), propose to enter into this agreement (this “Agreement”) to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $600,000,000 principal amount of the Company’s 2.150% Senior Unsecured Notes due 2031 (the “2031 Notes”) and $700,000,000 principal amount of the Company’s 3.350% Senior Unsecured Notes due 2051 (the “2051 Notes” and, together with the 2031 Notes, the “Securities”). The Securities will be issued pursuant to an indenture dated as of September 2, 2020 (the “Base Indenture”) among the Company, the Guarantor and Wilmington Trust Nat
